Ponoi Capital II, LP insider trades: Ngm Biopharmaceuticals (NGM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ponoi Capital II, LP reports to the SEC
Open-market buys and sales
78 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | NGM | ↑ Buy | 22,631 | $0.69 | $16K | Indirect | Nov 17, 2023 (1d) |
| Jan 31, 2023 | NGM | ↑ Buy | 184,272 | $5.00 | $921K | Indirect | Feb 1, 2023 (1d) |
| Jan 23, 2023 | NGM | ↑ Buy | 9,900 | $5.00 | $49K | Indirect | Jan 25, 2023 (2d) |
| Jan 20, 2023 | NGM | ↑ Buy | 38,139 | $5.00 | $191K | Indirect | Jan 23, 2023 (3d) |
| Jan 12, 2023 | NGM | ↑ Buy | 5,378 | $4.95 | $27K | Indirect | Jan 17, 2023 (5d) |
| Jan 11, 2023 | NGM | ↑ Buy | 309,070 | $4.79 | $1.5M | Indirect | Jan 12, 2023 (1d) |
| Dec 12, 2022 | NGM | ↑ Buy | 300 | $4.98 | $1K | Indirect | Dec 14, 2022 (2d) |
| Nov 22, 2022 | NGM | ↑ Buy | 40,327 | $5.00 | $202K | Indirect | Nov 23, 2022 (1d) |
| Nov 4, 2022 | NGM | ↑ Buy | 139,148 | $4.92 | $684K | Indirect | Nov 7, 2022 (3d) |
| Oct 27, 2022 | NGM | ↑ Buy | 76,877 | $4.86 | $374K | Indirect | Oct 31, 2022 (4d) |
| Oct 26, 2022 | NGM | ↑ Buy | 123,820 | $4.81 | $595K | Indirect | Oct 27, 2022 (1d) |
| Jun 9, 2022 | NGM | ↑ Buy | 984,161 | $13.50 | $13.3M | Indirect | Jun 13, 2022 (4d) |
| Jun 2, 2022 | NGM | ↑ Buy | 34,200 | $13.03 | $446K | Indirect | Jun 6, 2022 (4d) |
| Jun 1, 2022 | NGM | ↑ Buy | 153,806 | $13.46 | $2.1M | Indirect | Jun 2, 2022 (1d) |
| May 27, 2022 | NGM | ↑ Buy | 22,911 | $13.49 | $309K | Indirect | May 31, 2022 (4d) |
| May 25, 2022 | RAPT | ↑ Buy | 1,900 | $12.45 | $24K | Indirect | May 27, 2022 (2d) |
| May 25, 2022 | NGM | ↑ Buy | 61,120 | $13.42 | $820K | Indirect | May 26, 2022 (1d) |
| May 24, 2022 | RAPT | ↑ Buy | 26,550 | $12.19 | $324K | Indirect | May 25, 2022 (1d) |
| May 20, 2022 | NGM | ↑ Buy | 39,700 | $13.36 | $530K | Indirect | May 23, 2022 (3d) |
| May 18, 2022 | NGM | ↑ Buy | 151,699 | $13.33 | $2.0M | Indirect | May 19, 2022 (1d) |
| May 16, 2022 | NGM | ↑ Buy | 33,166 | $12.90 | $428K | Indirect | May 17, 2022 (1d) |
| May 12, 2022 | NGM | ↑ Buy | 166,350 | $11.43 | $1.9M | Indirect | May 13, 2022 (1d) |
| May 10, 2022 | RAPT | ↑ Buy | 1,250,000 | $10.67 | $13.3M | Indirect | May 12, 2022 (2d) |
| May 10, 2022 | NGM | ↑ Buy | 114,440 | $10.95 | $1.3M | Indirect | May 11, 2022 (1d) |
| Sep 27, 2021 | RAPT | ↓ Sell | 9,239 | $34.57 | $319K | Indirect | Sep 29, 2021 (2d) |
| Sep 15, 2021 | RAPT | ↓ Sell | 181,211 | $37.01 | $6.7M | Indirect | Sep 16, 2021 (1d) |
| Sep 13, 2021 | RAPT | ↓ Sell | 36,055 | $35.22 | $1.3M | Indirect | Sep 14, 2021 (1d) |
| Sep 2, 2021 | RAPT | ↓ Sell | 68,850 | $35.34 | $2.4M | Indirect | Sep 3, 2021 (1d) |
| Aug 24, 2021 | RAPT | ↓ Sell | 95,746 | $31.30 | $3.0M | Indirect | Aug 24, 2021 (0d) |
| Feb 17, 2021 | CNST | ↓ Sell | 10,000 | $36.95 | $370K | Indirect | Feb 19, 2021 (2d) |
| Nov 16, 2020 | RVMD | ↓ Sell | 1,075,133 | $36.40 | $39.1M | Indirect | Nov 18, 2020 (2d) |
| Nov 16, 2020 | RVMD | ↓ Sell | 952,023 | $36.40 | $34.7M | Direct | Nov 18, 2020 (2d) |
| Sep 22, 2020 | RAPT | ↓ Sell | 608,000 | $30.85 | $18.8M | Direct | Sep 23, 2020 (1d) |
| Sep 2, 2020 | NGM | ↑ Buy | 64,089 | $17.65 | $1.1M | Direct | Sep 3, 2020 (1d) |
| Aug 28, 2020 | NGM | ↑ Buy | 62,494 | $17.83 | $1.1M | Direct | Aug 31, 2020 (3d) |
| Aug 25, 2020 | NGM | ↑ Buy | 18,445 | $17.96 | $331K | Direct | Aug 25, 2020 (0d) |
| Aug 17, 2020 | RAPT | ↓ Sell | 538,654 | $22.75 | $12.3M | Direct | Aug 19, 2020 (2d) |
| Aug 17, 2020 | NGM | ↑ Buy | 64,313 | $17.65 | $1.1M | Direct | Aug 17, 2020 (0d) |
| Jul 30, 2020 | NGM | ↑ Buy | 732 | $17.99 | $13K | Direct | Aug 3, 2020 (4d) |
| Jul 28, 2020 | NGM | ↑ Buy | 4,105 | $17.99 | $74K | Direct | Jul 30, 2020 (2d) |
| Jul 27, 2020 | NGM | ↑ Buy | 72,583 | $17.93 | $1.3M | Direct | Jul 28, 2020 (1d) |
| Jul 22, 2020 | NGM | ↑ Buy | 193 | $18.00 | $3K | Direct | Jul 23, 2020 (1d) |
| Apr 8, 2020 | NGM | ↑ Buy | 112,602 | $14.95 | $1.7M | Direct | Apr 9, 2020 (1d) |
| Apr 7, 2020 | NGM | ↑ Buy | 138,315 | $14.17 | $2.0M | Direct | Apr 7, 2020 (0d) |
| Apr 2, 2020 | NGM | ↑ Buy | 250,984 | $12.40 | $3.1M | Direct | Apr 2, 2020 (0d) |
| Mar 25, 2020 | NGM | ↑ Buy | 301,180 | $11.89 | $3.6M | Direct | Mar 25, 2020 (0d) |
| Mar 20, 2020 | NGM | ↑ Buy | 291,546 | $11.68 | $3.4M | Direct | Mar 23, 2020 (3d) |
| Mar 20, 2020 | CNST | ↑ Buy | 41,674 | $22.48 | $937K | Direct | Mar 23, 2020 (3d) |
| Mar 5, 2020 | NGM | ↑ Buy | 8,307 | $18.00 | $150K | Direct | Mar 6, 2020 (1d) |
| Mar 4, 2020 | NGM | ↑ Buy | 62,868 | $17.97 | $1.1M | Direct | Mar 4, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ponoi Capital II, LP's insider trades
Ponoi Capital II, LP is a 10% owner of Ngm Biopharmaceuticals (NGM). Since Apr 8, 2019, it has reported 68 open-market purchases worth $126.9M and 10 sales worth $118.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (7 filings), conversions (5 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NGM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.